ロード中...
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation
Lung cancer is still the main cause of cancer-related deaths worldwide, with most patients present with advanced disease and poor long-term prognosis. The aim of lung cancer treatment is to slow down the progression of the disease, to relieve the patients from the lung cancer symptoms and whenever p...
保存先:
| 出版年: | J Nat Sci Biol Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934098/ https://ncbi.nlm.nih.gov/pubmed/27433059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-9668.184695 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|